宫颈上皮细胞FH/ROS联合检测在宫颈癌筛查中的临床应用价值
Clinical Application Value of FH/ROS Combined Test in Cervical Cancer Screening

DOI: 10.12677/HJBM.2019.94022, PP. 149-153

Keywords: 细胞游离亚铁原卟啉，活性氧自由基，宫颈癌，宫颈上皮内瘤变，液基薄层细胞检测，FH/ROS联合检测
Cell Free Ferrous Porphyrin, Reactive Oxygen Free Radical, Cervical Cancer, Cervical Intraepithelial Neoplasia, Detection of Thin Layer Cells in Liquid Base, FH/ROS Combined Test

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的：探讨宫颈上皮细胞游离亚铁原卟啉/活性氧自由基(FH/ROS)联合检测在宫颈癌及癌前病变中的临床应用价值。方法：2019年3月至2019年6月遵义医科大学附属妇幼保健院(遵义市妇幼保健院)妇科接受宫颈癌筛查的女性患者360例，选取同时具有TCT检测及病理检查结果的300例，对其FH/ROS联合检测，以病理学诊断结果作为金标准，分析FH/ROS联合检测和TCT对宫颈癌与CIN检测的灵敏度、特异度、准确度。结果：上皮细胞FH/ROS联合检测阳性率高于TCT (P < 0.05)，其灵敏度、特异度、准确度分别是100%、85.7%、91.3%，TCT检测的灵敏度、特异度、准确度分别为82.05%、81.4%、85.3%。结论：FH/ROS联合检测作为宫颈癌筛查方法具有简便快速，检测成本较低，灵敏度较高等特点，值得临床推广应用。
Objective: To investigate the clinical significance of free ferrous porphyrin/reactive oxygen free radical (FH/ROS) combined test in cervical cancer screening. Methods: A total of 300 women pathologically diagnosed with cervical intraepithelial neoplasia (CIN), cervical cancer and normal cervix were detected by FH/ROS combined test and thin-prep cytology test (TCT). The sensitivity, specificity and accuracy of TCT and FH/ROS combined test for cervical lesions were compared. Results: The positive rate of FH/ROS combined test was higher than TCT (P < 0.05), the sensitivity, specificity and accuracy of FH/ROS combined test were 100%, 85.7% and 91.3%, respectively, and the sensitivity, specificity and accuracy of TCT were 82.05%, 81.4% and 85.3% respectively. Conclusion: FH/ROS combined test has simple, fast, low-cost advantages and high sensitivity of detection, which is worthy to be used as clinical early warning detection technology in cervical cancer screening.

References

[1]	Ma, J., Chai, C., Liu, Y., et al. (2018) The Value of Epithelial Cell Stable Free Body of Iron Protoporphyrin Reduced State Detection in the Diagnosis of Cervical Cancer. Biomedical Research, 29, 103-107. https://doi.org/10.4066/biomedicalresearch.29-17-2640
[2]	Liu, Y., Guo, J.-Z., Liu, Y., et al. (2018) Nuclear Lactate Dehydrogenase A Senses ROS to Produce α-Hydroxybutyrate for HPV-Induced Cervical Tumor Growth. Nature Communications, 9, 4429-4445. https://doi.org/10.1038/s41467-018-06841-7
[3]	何慧娟. 活性氧在宫颈癌形成中的作用[J]. 国际病理科学与临床杂志, 2009, 29(5): 426-430.
[4]	李姗, 宗丽菊, 孟丽华, 等. 子宫上皮细胞稳定性FH检测在诊断宫颈癌及癌前病变中的临床意义[J]. 中国肿瘤, 2015, 24(10): 881-883.
[5]	Wasim, L. and Chopra, M. (2016) Panobinostat Induces Apoptosis via Production of Reactive Oxygen Species and Synergizes with Topoisomerase Inhibitors in Cervical Cancer Cells. Biomedicine & Pharmacotherapy, 4453, 13-26. https://doi.org/10.1016/j.biopha.2016.10.057
[6]	员周慧, 余晓, 徐舜, 等. 子宫上皮细胞稳定性FH检测在宫颈癌前病变中的临床诊断意义分析[J]. 中国性科学, 2016, 25(11): 39-41.
[7]	Beevi, S.S., Rasheed, M.H. and Geetha, A. (2007) Evidence of Oxidative and Nitrosative Stress in Patients with Cervical Quamous Cell Carcinoma. Clinica Chimica Acta, 375, 119-123. https://doi.org/10.1016/j.cca.2006.06.028
[8]	陈艳辉, 周训华, 赵莹, 等. 子宫上皮细胞稳定性细胞游离亚铁原卟啉对宫颈癌的诊断意义[J]. 中国医药导报, 2018, 15(2): 79-82.
[9]	施丽洁. 宫颈上皮细胞稳定性FH检测在诊断宫颈癌病变中的临床意义[J]. 中国医药导报, 中国现代药物应用, 2017, 11(16): 45-46.
[10]	熊珊珊, 石英英, 石汉平. 活性氧与肿瘤研究进展[J]. 中华肿瘤防治杂志, 2014, 21(13): 1045-1048.

Full-Text